Inhibition of HIV-1 replication by RNA interference of p53 expression

Journal of Leukocyte Biology

Volumn 80, Issue 3, 2006, Pages 659-667

  Pauls, Eduardo ^a   Senserrich, Jordi ^a   Clotet, Bonaventura ^a   Esté, Jose A ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Apoptosis; shRNA; Silencing; Transcription

Indexed keywords

ALPHA INTERFERON; PROTEIN P53; SHORT HAIRPIN RNA; TRANSACTIVATOR PROTEIN;

ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL DEATH; DNA BINDING; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA INTERFERENCE; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS VECTOR;

CELL DEATH; CELL LINE; GENE EXPRESSION PROFILING; GIANT CELLS; HELA CELLS; HIV-1; HUMANS; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33751526281     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0306189     Document Type: Article

References (46)

1. Genini, D., Sheeter, D., Rought, S., Zaunders, J. J., Susin, S. A., Kroemer, G., Richman, D. D., Carson, D. A., Corbeil, J., Leoni, L. M. (2001) HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J. 15, 5-6.
2. Duan, L., Ozaki, I., Oakes, J. W., Taylor, J. P., Khalili, K., Pomerantz, R. J. (1994) The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. J. Virol. 68, 4302-4313.
3. Subler, M. A., Martin, D. W., Deb, S. (1994) Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53. J. Virol. 68, 103-110.
4. Chicas, A., Molina, P., Bargonetti, J. (2000) Mutant p53 forms a complex with Sp1 on HIV-LTR DNA. Biochem. Biophys. Res. Commun. 279, 383-390.
5. Gualberto, A., Baldwin Jr., A. S. (1995) p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat. J. Biol. Chem. 270, 19680-19683.
6. Gualberto, A., Hixon, M. L., Finco, T. S., Perkins, N. D., Nabel, G. J., Baldwin Jr., A. S. (1995) A proliferative p53-responsive element mediates tumor necrosis factor α induction of the human immunodeficiency virus type 1 long terminal repeat. Mol. Cell. Biol. 15, 3450-3459.
7. Olszewski, A., Sato, K., Aron, Z. D., Cohen, F., Harris, A., McDougall, B. R., Robinson Jr., W. E., Overman, L. E., Weiss, G. A. (2004) Guanidine alkaloid analogs as inhibitors of HIV-1 Nef interactions with p53, actin, and p56lck. Proc. Natl. Acad. Sci. USA 101, 14079-14084.
8. Bakhanashvili, M., Novitsky, E., Lilling, G., Rahav, G. (2004) p53 in cytoplasm may enhance the accuracy of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Oncogene 23, 6890-6899.
9. Bakhanashvili, M. (2001) p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Oncogene 20, 7635-7644.
10. Castedo, M., Roumier, T., Blanco, J., Ferri, K. F., Barretina, J., Tintignac, L. A., Andreau, K., Perfettini, J. L., Amendola, A., Nardacci, R., et al. (2002) Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J. 21, 4070-4080.
11. Ferri, K. F., Jacotot, E., Blanco, J., Este, J. A., Zamzami, N., Susin, S. A., Xie, Z., Brothers, G., Reed, J. C., Penninger, J. M., Kroemer, G. (2000) Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J. Exp. Med. 192, 1081-1092.
12. Perfettini, J. L., Roumier, T., Castedo, M., Larochette, N., Boya, P., Raynal, B., Lazar, V., Ciccosanti, F., Nardacci, R., Penninger, J., Piacentini, M., Kroemer, G. (2004) NF-κB and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope. J. Exp. Med. 199, 629-640.
13. Hannon, G. J., Rossi, J. J. (2004) Unlocking the potential of the human genome with RNA interference. Nature 431, 371-378.
14. Martinez, M. A., Clotet, B., Este, J. A. (2002) RNA interference of HIV replication. Trends Immunol. 23, 559-561.
15. Martinez, M. A., Gutierrez, A., Armand-Ugon, M., Blanco, J., Parera, M., Gomez, J., Clotet, B., Este, J. A. (2002) Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 16, 2385-2390.
16. Dave, R. S., Pomerantz, R. J. (2004) Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains. J. Virol. 78, 13687-13696.
17. Chiu, Y-L., Cao, H., Jacque, J-M., Stevenson, M., Rana, T. M. (2004) Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/cyclinT1). J. Virol. 78, 2517-2529.
18. Berkhout, B. (2004) RNA interference as an antiviral approach: targeting HIV-1. Curr. Opin. Mol. Ther. 6, 141-145.
19. Pauls, E., Este, J. A. (2004) RNA interference as a tool for target validation. Drug Disc. Today: Technol. 1, 135-140.
20. Barton, G. M., Medzhitov, R. (2002) Retroviral delivery of small interfering RNA into primary cells. Proc. Natl. Acad. Sci. USA 99, 14943-14945.
21. Brummelkamp, T. R., Bernards, R., Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553.
22. Gupta, S., Schoer, R. A., Egan, J. E., Hannon, G. J., Mittal, V. (2004) From the cover: inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 101, 1927-1932.
23. Lee, N. S., Dohjima, T., Bauer, G., Li, H., Li, M. J., Ehsani, A., Salvaterra, P., Rossi, J. (2002) Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20, 500-505.
24. Fan, Z., Beresford, P. J., Zhang, D., Xu, Z., Novina, C. D., Yoshida, A., Pommier, Y., Lieberman, J. (2003) Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat. Immunol. 4, 145-153.
25. Bosch, B., Blanco, J., Clotet-Codina, I., Pauls, E., Armand-Ugon, M., Grigorov, B., Muriaux, D., Clotet, B., Darlix, J., Este, J. A. (2005) Inhibition of coreceptor independent cell-to-cell HIV-1 transmission by a CD4-IgG2 fusion protein. Antimicrob. Agents Chemother. 49, 4296-4304.
26. Blanco, J., Bosch, B., Fernandez-Figueras, M. T., Barretina, J., Clotet, B., Este, J. A. (2004) High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells. J. Biol. Chem. 279, 51305-51314.
27. Este, J. A. (2003) Virus entry as a target for anti-HIV intervention. Curr. Med. Chem. 10, 1617-1632.
28. Tang, S., Tao, M., McCoy, J. P., Zheng, Z. M. (2006) Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene 25, 2094-2104.
29. Hengstermann, A., D'Silva, M. A., Kuballa, P., Butz, K., Hoppe-Seyler, F., Scheffner, M. (2005) Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53. J. Virol. 79, 9296-9300.
30. Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A. L., Iggo, R. (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263-264.
31. Zhang, W., Funk, W. D., Wright, W. E., Shay, J. W., Deisseroth, A. B. (1993) Novel DNA binding of p53 mutants and their role in transcriptional activation. Oncogene 8, 2555-2559.
32. Bennasser, Y., Le, S. Y., Benkirane, M., Jeang, K. T. (2005) Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22, 607-619.
33. Barretina, J., Blanco, J., Armand-Ugon, M., Gutierrez, A., Clotet, B., Este, J. A. (2003) Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death. Antivir. Ther. 8, 155-161.
34. Garg, H., Blumenthal, R. (2006) HIV gp41-induced apoptosis is mediated by caspase-3-dependent mitochondrial depolarization, which is inhibited by HIV protease inhibitor nelfinavir. J. Leukoc. Biol. 79, 351-362.
35. Blanco, J., Barretina, J., Ferri, K. F., Jacotot, E., Gutierrez, A., Armand-Ugon, M., Cabrera, C., Kroemer, G., Clotet, B., Este, J. A. (2003) Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events. Virology 305, 318-329.
36. Blanco, J., Barretina, J., Clotet, B., Este, J. A. (2004) R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism. J. Leukoc. Biol. 76, 804-811.
37. Castedo, M., Ferri, K. F., Blanco, J., Roumier, T., Larochette, N., Barretina, J., Amendola, A., Nardacci, R., Metivier, D., Este, J. A., Piacentini, M., Kroemer, G. (2001) Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J. Exp. Med. 194, 1097-1110.
38. Li, C. J., Wang, C., Friedman, D. J., Pardee, A. B. (1995) Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92, 5461-5464.
39. Greenway, A. L., McPhee, D. A., Allen, K., Johnstone, R., Holloway, G., Mills, J., Azad, A., Sankovich, S., Lambert, P. (2002) Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J. Virol. 76, 2692-2702.
40. Sawaya, B. E., Khalili, K., Mercer, W. E., Denisova, L., Amini, S. (1998) Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J. Biol. Chem. 273, 20052-20057.
41. McLinden, R. J., Lewis, B., Michael, N. L., Redfield, R. R., Birx, D. L., Kim, J. H. (1997) Correlation of tumor suppressor p53 RNA expression with human immunodeficiency virus disease in rapid and slow progressors. J. Hum. Virol. 1, 30-36.
42. Charneau, P., Mirambeau, G., Roux, P., Paulous, S., Buc, H., Clavel, F. (1994) HIV-1 reverse transcription. A termination step at the center of the genome. J. Mol. Biol. 241, 651-662.
43. Gohler, T., Jager, S., Warnecke, G., Yasuda, H., Kim, E., Deppert, W. (2005) Mutant p53 proteins bind DNA in a DNA structure-selective mode. Nucleic Acids Res. 33, 1087-1100.
44. Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L., Cho, K. R. (1993) Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 90, 3988-3992.
45. Hietanen, S., Lain, S., Krausz, E., Blattner, C., Lane, D. P. (2000) Activation of p53 in cervical carcinoma cells by small molecules. Proc. Natl. Acad. Sci. USA 97, 8501-8506.
46. Harrod, R., Nacsa, J., Van Lint, C., Hansen, J., Karpova, T., McNally, J., Franchini, G. (2003) Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription. J. Biol. Chem. 278, 12310-12318.